Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29264904 | 0.98 | — | — | |
| SCHEMBL271597 | 0.98 | — | — | |
| Tetrazole SCHEMBL7464577 | 0.80 | — | — | |
| SCHEMBL4408056 | 0.71 | PKM (0.30) | — | |
| SCHEMBL4407193 | 0.71 | — | — | |
| Potassium Ion SCHEMBL2216924 | 0.71 | CYP1A2 (0.34) | — | |
| SCHEMBL4407447 | 0.71 | — | — | |
| SCHEMBL4413156 | 0.67 | — | — | |
| SCHEMBL4405934 | 0.67 | — | — | |
| SCHEMBL4410969 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 400 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024218665-A1 | METHOD FOR IN VITRO ASSESSMENT OF THE CHEMOSENSITIVITY OF NEOPLASTIC CELLS TO ANTINEOPLASTIC DRUGS AND METHOD FOR EX VIVO DIAGNOSTICS OF BREAST NEOPLASM | UNIWERSYTET MEDYCZNY W BIAŁYMSTOKU (PL) | 2024-10-24 | — | — | WO | claimed |
| US-20240310288-A1 | TETRAZOLIUM-BASED COLORIMETRIC ASSAY | UNIVERSITY OF SOUTH CAROLINA | 2024-09-19 | — | — | US | claimed |
| CN-117923449-A | Method for promoting synthesis of blue iron ore by adding catalpa ovata fruit biochar | 北京工业大学 | 2024-04-26 | — | — | CN | claimed |
| CN-117625735-A | Reagent and kit for detecting beta-hydroxybutyric acid | 迪瑞医疗科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-113278675-B | Preparation method of lactate dehydrogenase determination reagent ball, reagent ball and microfluidic chip | 深圳市锦瑞生物科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-11650203-B2 | One-pot biosensor and immunoassay method using the same | GIST (Gwangju Institute of Science and Technology) (KR) | 2023-05-16 | — | — | US | claimed |
| CN-116121332-A | Helicobacter pylori minimum inhibition concentration detection kit and application method thereof | 上海交通大学医学院附属仁济医院 | 2023-05-16 | — | — | CN | claimed |
| US-20210405042-A1 | ONE-POT BIOSENSOR AND IMMUNOASSAY METHOD USING THE SAME | GIST (Gwangju Institute of Science and Technology) (KR) | 2021-12-30 | — | — | US | claimed |
| CN-113278675-A | Preparation method of lactate dehydrogenase determination reagent ball, reagent ball and microfluidic chip | 深圳市锦瑞生物科技有限公司 | 2021-08-20 | — | — | CN | claimed |
| CN-111735811-A | Triglyceride detection reagent, triglyceride detection test paper and preparation method of triglyceride detection test paper | 民康医疗科技（天津）有限公司 | 2020-10-02 | — | — | CN | claimed |
| US-6864272-B2 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2005-03-08 | — | — | US | claimed |
| US-6703216-B2 | AN OXIDIZED COFACTOR FOR THE FIRST OXIDOREDUCTASE THAT IS REDUCED UPON OXIDATION OF GHB BY THE FIRST OXIDOREDUCTASE IS IN TURN OXIDIZED BY ANOTHER OXIDOREDUCTASE CAUSING DETECTABLE CONVERSION OF CHROMOGEN OR DYE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-03-09 | — | — | US | claimed |
| US-20030175846-A1 | Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB) | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2003-09-18 | — | — | US | claimed |
| US-20020143042-A1 | Method and composition for treating cancer using cellular organelle crystallizing agents | KONG QINGZHONG (US) | 2002-10-03 | — | — | US | claimed |
| US-20020086345-A1 | Methods and compositions for the visualization of cellular organelles using tetrazolium salts | KONG QINGZHONG (US) | 2002-07-04 | — | — | US | claimed |
| US-6376525-B1 | Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments | KONG QINGZHONG (US) | 2002-04-23 | — | — | US | claimed |
| EP-0654079-A4 | A REAGENT STABILIZED BY BIVALENT METAL SALTS. | BOEHRINGER MANNHEIM CORP (US) | 1996-10-02 | — | — | EP | claimed |
| EP-0654079-A1 | A REAGENT STABILIZED BY BIVALENT METAL SALTS | BOEHRINGER MANNHEIM CORPORATION (US) | 1995-05-24 | — | — | EP | claimed |
| US-5290683-A | Solid carrier impregnated with solution of crosslinked and stabilized alcohol dehydrogenase and diaphorase, competitive binder for alcohol dehydrogenase, chromogen and buffer | KAPUR, BHUSHAN (CA) | 1994-03-01 | — | — | US | claimed |
| WO-1994001544-A1 | A REAGENT STABILIZED BY BIVALENT METAL SALTS | BOEHRINGER MANNHEIM CORPORATION (US) | 1994-01-20 | — | — | WO | claimed |